Publications

Ali Tavassoli, et al, Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells, Journal of the American Chemical Society 146 (2024), 8877-8886, https://pubs.acs.org/doi/full/10.1021/jacs.3c10508

Ali Tavassoli, et al, Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery, Nature Reviews Chemistry 4 (2020), 90-101, https://www.nature.com/articles/s41570-019-0159-2

Ali Tavassoli, SICLOPPS cyclic peptide libraries in drug discovery, Current Opinion in Chemical Biology 38 (2017), 30-35, https://www.sciencedirect.com/science/article/abs/pii/S1367593116301818?via%3Dihub

Ali Tavassoli, et al, AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization, Chemistry & Biology 22 (2015), 838-848, https://www.sciencedirect.com/science/article/pii/S1074552115002343?via%3Dihub

Ali Tavassoli, et al, A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells, Journal of the American Chemical Society 135 (2013), 10418-10425, https://pubs.acs.org/doi/10.1021/ja402993u